FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

386640004: Product containing gemtuzumab ozogamicin (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1460819011 Gemtuzumab ozogamicin (product) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
1480782013 Gemtuzumab ozogamicin en Synonym Inactive Entire term case insensitive SNOMED CT core module
3523390012 Product containing gemtuzumab ozogamicin (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3523391011 Product containing gemtuzumab ozogamicin en Synonym Inactive Entire term case insensitive SNOMED CT core module
3671724016 Gemtuzumab ozogamicin product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3715003013 Gemtuzumab ozogamicin-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
107811101000001115 Gemtuzumab ozogamicin en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing gemtuzumab ozogamicin Is a Product containing monoclonal antibody false Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Is a Medicinal product acting as antineoplastic agent (product) false Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Has active ingredient Gemtuzumab ozogamicin true Inferred relationship Existential restriction modifier 1
Product containing gemtuzumab ozogamicin Has active ingredient Immunosuppressant false Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Has active ingredient Biological agent false Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Has active ingredient Antineoplastic agent false Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Is a Product containing immunomodulator true Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Is a Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) true Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin Is a Virtual therapeutic moiety false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Is a False Product containing gemtuzumab ozogamicin Inferred relationship Existential restriction modifier
Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form) Is a True Product containing gemtuzumab ozogamicin Inferred relationship Existential restriction modifier
Gemtuzumab ozogamicin Is a True Product containing gemtuzumab ozogamicin Inferred relationship Existential restriction modifier
Gemtuzumab 5mg powder for solution for infusion vials Is a False Product containing gemtuzumab ozogamicin Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start